Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Photobiomodulation on Performance in Female Futsal Athletes

NCT: NCT07511790 · NOT_YET_RECRUITING

NCT IDNCT07511790
StatusNOT_YET_RECRUITING
Start Date2026-04-15
Completion2026-06-10

Brief Summary

The aim of this study is to investigate the effects of photobiomodulation therapy (PBMT) on physical performance in female futsal athletes. It is hypothesized that PBMT is superior to placebo condition in improving the ability to perform repeated sprints and aerobic capacity in high-intensity, intermittent activity (i.e., Bangsbo sprint test and yoyo intermittent recovery level-1, respectively).

Frequently Asked Questions

What is Photobiomodulation on Performance in Female Futsal Athletes?

Photobiomodulation on Performance in Female Futsal Athletes is a clinical trial registered under NCT07511790. Current status: NOT_YET_RECRUITING.

What is the status of NCT07511790?

The current status of NCT07511790 (Photobiomodulation on Performance in Female Futsal Athletes) is: NOT_YET_RECRUITING.

When did Photobiomodulation on Performance in Female Futsal Athletes start?

Photobiomodulation on Performance in Female Futsal Athletes started on 2026-04-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.